Study finds drug industry 'exaggerated' swine flu risks for profit

Large pharmaceutical companies are in business to make money, just like every other large corporation. So, when a new study published in BMJ finds the drug industry exaggerated the risk of swine flu (H1N1) and in turn made billions of dollars, we really shouldn’t be surprised.

According to the study “Academics and competing interests in H1N1 influenza medial reporting,”.. Read more.

Allvoices

Related,
- 38 sue swine flu drug firm over complaints of rare sleep disorder after Pandemrix jab - Independent
- Britten overdreven Mexicaanse griep - NOS